跳至主要内容
临床试验/CTRI/2018/02/011928
CTRI/2018/02/011928已完成未知

To evaluate the Safety & Efficacy of Facial Oxylife Spot Reduction Bleach System

Dabur India Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Female Adult Subjects in general good health with age group of 18 to 60 years. Subjects who have not undergone any bleaching or facial procedure in past 6 weeks.
  • 2. Subjects willing to give a voluntary written informed consent for the participation in study and also photography release and agree to come for regular follow up.
  • 3. Subjects willing to abide by and comply with the study protocol.
  • 4. Subjects who are willing not to participate in any other clinical study during participation in the current study.
  • 5. Subjects who will qualify the sensitivity test will be enrolled in the study.

排除标准

  • 1. A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients, or any ingredient of the test product.
  • 2. Present/current of intense sun exposure.
  • 3. Female volunteers with positive pregnancy test.
  • 4. Presence of any underlying clinically significant uncontrollable medical conditions
  • 5. Subject having active skin diseases (e.g. mild, moderate to severe acne vulgaris on the face or nodulocystic acne, psoriasis, active atopic dermatitis, lichen planus pigmentosus/Ashy dermatosis, pigmented contact dermatitis and active seborrhoeic dermatitis, tinea faciei or other cutaneous manifestations), which may interfere with the test readings.
  • 6. Subject on systematic medications (e.g. steroids, anti-oxidant) which may compromise the study.
  • 7. Subjects who have excessive facial hair

研究者

相似试验

To evaluate the safety & efficacy of Facial Oxylife... | 临床试验